On 13-14 January, the ADIS project consortium came together online for their third General Assembly. ADIS stands for “Early Diagnosis of Alzheimer’s Disease by Immune Profiling of Cytotoxic Lymphocytes and Recording of Sleep Disturbances”. The project is funded by the Joint Programme for Neurodegenerative diseases (JPND) for three years and will conclude at the end of June in 2025.
Day 1 began with an introduction by Holger Fröhlich (Project Coordinator, Fraunhofer SCAI) and Vanessa Lage-Rupprecht followed by discussions on WP1, which covered milestone updates, risk mitigation strategies, and dissemination efforts. Vanessa Lage-Rupprecht also presented on the plans for the final symposium and provided an overview of project deliverables.
The following discussions (WP2) focused on experimental approaches, data transfer, and analysis timeframes, with ITEM-R (Sarah Hücker and Stefan Kirsch) leading the session. WP3 followed, addressing the Data Management Plan, sustainability planning and catalogue updates. The day ended with an interesting guest talk by Prof. Jochen Klucken (University of Luxembourg, CHL) about the use of Artificial Intelligence in medicine.
Day 2 opened with WP4 sessions on modelling, exploring agent-based approaches that were led by partners from Tel Aviv University, Shir Bahiri, Axel Roussay and Uri Nevo. Sophia Krix (Fraunhofer SCAI) continued with an overview of her work in progress related to Artificial Intellgience and statistical techniques.
Soraya Moradi-Bachiller presented updates on the brain health campaign as part of her Public Involvement work. The General Assembly concluded with plans to draft a publication roadmap and a review of action items that arose during the meeting.
